文献速递胃肠外科围术期管理与 ERAS

减重手术后体重反弹的患者视角:一项单中心调查

Patients' perspectives on weight recurrence after bariatric surgery: a single-center survey.
PubMed 文献 · Surg Endosc · 2024-02-26

该单中心调查于2021至2023年通过18项网络问卷和在线招募,纳入56例初次减重手术后体重较最低点增加超过10%的成人患者,评估其对体重反弹治疗的需求、目标与偏好。患者选择治疗时最看重减重等预期获益,再次减重手术和生活方式改变较减重药物更受青睐,作者指出需要大型前瞻性随机试验以更好地为该人群提供咨询。

要点

  • 56例初次减重手术后体重较最低点增加超过10%的患者参与调查。
  • 选择体重反弹治疗时,患者认为减重等预期获益是最重要因素。
  • 40%的受访者将再次减重手术列为体重反弹的首选治疗。

核心结论

  • 患者选择体重反弹治疗方式时认为减重是最重要因素,再次减重手术和生活方式改变较减重药物更受青睐。
  • 需要大型前瞻性随机试验以更好地为该患者人群提供咨询。

研究设计与样本

  • 单中心MBSAQIP认证学术中心开展的网络问卷调查,辅以在线招募,于2021年至2023年发放18项网络问卷。
  • 纳入56例初次减重手术后体重较最低点增加超过10%的成人患者。

主要发现

  • 初次手术方式为Roux-en-Y胃旁路术(62.5%)、袖状胃切除术(28.6%)、可调节胃束带术(3.6%)或其他手术(5.3%)。
  • 对初次减重手术的满意度:57.1%有点/极其满意,33.9%有点/极其不满意,8.9%态度矛盾。
  • 患者目标中「自我感觉良好」96.4%认为非常/极其重要,「能恢复以前无法进行的活动」91%认为非常/极其重要,「改善生活质量」和「改善预期寿命」均超过90%认为非常/极其重要。
  • 将再次减重手术、带同伴支持的生活方式调整和抗肥胖药物列为体重反弹首选治疗的患者分别占40%、38.8%和29.8%。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Weight recurrence (WR) affects nearly 20% of patients after bariatric surgery and may decrease its benefits, affecting patients' quality of life negatively. Patient perspectives on WR are not well known. OBJECTIVES: Assess patient needs, goals, and preferences regarding WR treatment. SETTING: Single MBSAQIP-accredited academic center, and online recruitment. METHODS: An 18-item, web-based survey was distributed to adults seeking treatment for WR after a primary bariatric surgery (PBS), in addition to online recruitment, between 2021 and 2023. Survey items included somatometric data, questions about the importance of factors for successful weight loss, procedure decision-making, and treatment expectations. RESULTS: Fifty-six patients with > 10% increase from their nadir weight were included in the study. Patients had initially undergone Roux-en-Y gastric bypass (62.5%), sleeve gastrectomy (28.6%), adjustable gastric banding (3.6%), or other procedures (5.3%). When assessing their satisfaction with PBS, 57.1% were somewhat/extremely satisfied, 33.9% somewhat/extremely dissatisfied, while 8.9% were ambivalent. Patients considered the expected benefits (for example, weight loss) as the most important factor when choosing a treatment option for WR. Patient goals included "feeling good about myself" (96.4% very/extremely important), "being able to resume activities I could not do before" (91% very/extremely important), and "improved quality of life" and "-life expectancy" (> 90% very/extremely important). Finally, RBS, lifestyle modification with peer support, and anti-obesity medication were ranked as first treatment options for WR by 40%, 38.8%, and 29.8% of the respondents, respectively. CONCLUSIONS: Patients considered weight loss as the most important factor when choosing treatment modality for WR, with RBS and lifestyle changes being preferred over weight-loss medications. Large prospective randomized trials are needed to counsel this patient population better.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Giannopoulos S, AbuHasan Q, Connors JDN, et al. Patients' perspectives on weight recurrence after bariatric surgery: a single-center survey. Surg Endosc. 2024. PMID: 38409612. doi:10.1007/s00464-023-10664-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。